UNSPSC 51392602: Metaraminol

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H13NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 818U2PZ2EH, chemically known as benzyl alcohol, alpha-(1-aminoethyl)-m-hydroxy-, (-)- but generally known as metaraminol, which bears US NIH Compound Identifier 5906. European Medicines Agency schedules Metaraminol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08815MIG. The term METARAMINOL is an International Non-Proprietary Name.

UNSPSC 51392602 Metaraminol is a Commodity code representing pharmaceutical products procured by state and local health agencies for emergency medical response and community health initiatives. State and local governments buy naloxone and related drug-intervention pharmaceuticals under this code to support opioid overdose response programs, addiction treatment infrastructure, and public health emergency preparedness. The issuing bodies are typically county and municipal health departments and community health agencies managing overdose prevention and substance-use disorder programs.

Seminole County, Florida posted an IFB in June 2026 (due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement requires electronic bid submission through the county's e-Procurement Portal, with all shipping and delivery costs included in proposals. The contract carries a two-year initial term with a one-year renewal option, includes a three-month probationary period, and mandates E-Verify compliance, drug-free workplace certification, workers' compensation, commercial general liability, and professional liability insurance. The opportunity is potentially FEMA-funded and subject to federal environmental compliance requirements including the Clean Air Act and Federal Water Pollution Control Act.